Fennec Pharmaceuticals Inc.
FENCNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $367.21M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $5.65$13.25
- Volume (live)
- -
- Avg. volume (3M)
- 130.58K
Fennec Pharmaceuticals (FENC) Stock Price & Financial Analysis
Fennec Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $9.93 - $10.48 |
|---|---|
| 52-Week High | $13.25 |
| 52-Week Low | $5.65 |
| Open | $10.23 |
| Volume (last close) | 70.82K |
| Average Volume (3M) | 130.58K |
| Revenue (TTM) | 59.22M |
|---|---|
| Net Income (TTM) | -3.25M |
| Free Cash Flow (TTM) | -2.04M |
| EPS (TTM) | −$0.10 |
| Profit Margin | -5.49% |
| Operating Margin | -1.96% |
| Return on Equity (ROE) | -7.66% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 367.21M |
|---|---|
| Shares Outstanding | 36.43M |
| Price to Sales (P/S) | 6.20 |
| Price to Book (P/B) | 8.65 |
| EV/EBITDA | -159.69 |
| 50-Day MA | $11.17 |
|---|---|
| 200-Day MA | $9.09 |
| 1-Year Change | +15.18% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Fennec Pharmaceuticals at a Glance
As of the Oct 23, 2026 close, Fennec Pharmaceuticals (FENC) has a market capitalization of $367.21M. The stock trades at 6.2× sales. Over the trailing twelve months it lost $3.25M on revenue of $59.22M and burned $2.04M of free cash flow. Revenue grew 77.8% year over year.
As of its latest reported balance sheet, it holds $41.25M in cash and securities against $0.00 of debt, a net cash position of $41.25M.
Fennec Pharmaceuticals does not currently pay a dividend.
The share price is up 15.2% over the past year. At $10.08 (the Oct 23, 2026 close) it sits within its 52-week range of $5.65 to $13.25, above its 200-day moving average of $9.09.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $17.60, 74.6% above the Oct 23, 2026 close.
Frequently Asked Questions About Fennec Pharmaceuticals
What is the current stock price for FENC?
As of the Oct 23, 2026 close, FENC stock trades at $10.08. The 52-week range is $5.65–$13.25, with a day range of $9.93–$10.48.
What is the P/E ratio for FENC?
The P/E ratio (Price-to-Earnings) for FENC is shown in the Key Statistics section. This valuation metric helps compare Fennec Pharmaceuticals Inc. to industry peers.
Does FENC pay dividends?
Fennec Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for FENC?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for FENC is Buy. The average 12-month price target is $17.60, a 74.6% upside from the Oct 23, 2026 close of $10.08.
What is the market cap of FENC?
As of the Oct 23, 2026 close, Fennec Pharmaceuticals's market capitalization is $367.2M, classifying it as a small-cap company. Fennec Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.